Cocrystal Pharma, Inc.

COCP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$18-$18-$39-$14
Dep. & Amort.$0-$1$0$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.$1$1$1$1
Change in WC$0$2-$3$1
Other Non-Cash$0$2$19-$0
Operating Cash Flow-$16-$15-$21-$13
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0-$0
Financing Activities
Debt Repay.$0-$0-$0-$0
Stock Issued$0$4$0$39
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$4-$0$38
Forex Effect$0$0$0$0
Net Chg. in Cash-$16-$11-$22$26
Supplemental Information
Beg. Cash$26$37$59$33
End Cash$10$26$37$59
Free Cash Flow-$16-$15-$22-$13
Cocrystal Pharma, Inc. (COCP) Financial Statements & Key Stats | AlphaPilot